BlackRock Group’s Avanos Medical AVNS Stock Holding History

BlackRock Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.76M	Buy	182,833 +2,254	+1%	+$80.6K	﹤0.01%	1037
2016 Q3	$6.26M	Buy	180,579 +29,895	+20%	+$1.05M	﹤0.01%	1037
2016 Q2	$4.9M	Buy	150,684 +6,079	+4%	+$186K	﹤0.01%	1106
2016 Q1	$4.15M	Sell	144,605 -11,115	-7%	-$296K	﹤0.01%	1153
2015 Q4	$5.2M	Buy	155,720 +111,260	+250%	+$3.46M	﹤0.01%	1087
2015 Q3	$1.26M	Sell	44,460 -118,986	-73%	-$4.15M	﹤0.01%	1747
2015 Q2	$6.62M	Sell	163,446 -78,036	-32%	-$3.5M	﹤0.01%	1062
2015 Q1	$11.9M	Sell	241,482 -152,747	-39%	-$7.08M	0.01%	914
2014 Q4	$17.9M	Buy	+394,229	New	+$15.5M	0.01%	826

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BlackRock Group's AVNS Position: Q4 2016 in Review

BlackRock Group increased its Avanos Medical (AVNS) stake by 1.2% in Q4 2016, buying an estimated $80.6K and bringing the position to 182,833 shares worth $6.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

BlackRock Group first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. The position peaked at $17.9M in Q4 2014. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

BlackRock Group held 182,833 shares of Avanos Medical worth $6.76M as of Q4 2016.
BlackRock Group bought 2,254 Avanos Medical shares in Q4 2016, an estimated $80.6K.
Avanos Medical made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1037 holding.
BlackRock Group first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
BlackRock Group's Avanos Medical position peaked at $17.9M in Q4 2014.
360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.